3-(5-bromothiophen-2-yl)-5-methyl-1,2,4-oxadiazole

Modify Date: 2025-09-04 13:19:19

3-(5-bromothiophen-2-yl)-5-methyl-1,2,4-oxadiazole Structure
3-(5-bromothiophen-2-yl)-5-methyl-1,2,4-oxadiazole structure
Common Name 3-(5-bromothiophen-2-yl)-5-methyl-1,2,4-oxadiazole
CAS Number 180530-13-6 Molecular Weight 245.09600
Density 1.679g/cm3 Boiling Point 346ºC at 760mmHg
Molecular Formula C7H5BrN2OS Melting Point 54ºC
MSDS N/A Flash Point 163ºC

 Names

Name 3-(5-bromothiophen-2-yl)-5-methyl-1,2,4-oxadiazole

 Chemical & Physical Properties

Density 1.679g/cm3
Boiling Point 346ºC at 760mmHg
Melting Point 54ºC
Molecular Formula C7H5BrN2OS
Molecular Weight 245.09600
Flash Point 163ºC
Exact Mass 243.93100
PSA 67.16000
LogP 2.86900
Vapour Pressure 0.000119mmHg at 25°C
Index of Refraction 1.604

 MSDS

Name: 3-(5-Bromo-2-thienyl)-5-methyl-1 2 4-oxadiazole 97% Material Safety Data Sheet
Synonym:
CAS: 180530-13-6
Section 1 - Chemical Product MSDS Name:3-(5-Bromo-2-thienyl)-5-methyl-1 2 4-oxadiazole 97% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
180530-13-6 3-(5-Bromo-2-thienyl)-5-methyl-1,2,4-o 97% unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 180530-13-6: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: beige
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 53 - 55 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C7H5BrN2OS
Molecular Weight: 245.1

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents, amines.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide, hydrogen bromide, bromine.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 180530-13-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3-(5-Bromo-2-thienyl)-5-methyl-1,2,4-oxadiazole - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 180530-13-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 180530-13-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 180530-13-6 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Safety Information

Safety Phrases S24/25
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here
Related Compounds: More...
3-{[(5-Methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-1,2,4-oxadiazole
1119452-70-8
1-iodo-3-(5-methyl-[1,2,4]oxadiazol-3-yl)benzene
180530-09-0
7-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)-5-Methyl-[1,2,4]triazolo[1,5-a]pyrimidine
172527-65-0
N-hydroxy-4-(1-hydroxy-6-methylhepta-2,3,5-trien-2-yl)cyclohexene-1-carboxamide
404850-01-7
5-(3,5-dichlorophenyl)-3-pyridin-2-yl-1,2,4-oxadiazole
327056-07-5
3-(5-Methyl-1,2,4-oxadiazol-3-yl)pyridine
10350-69-3
3-(5-methoxy-6,7,8,9-tetrahydroimidazo[1,2-a]quinazolin-2-yl)-5-methyl-1,2,4-oxadiazole
106073-01-2
(3-(5-METHYL-1,2,4-OXADIAZOL-3-YL)PHENYL)BORONIC ACID
1217501-31-9
3-bromo-5-methyl-1,2,4-oxadiazole(SALTDATA: FREE)
1228427-07-3
N-(3-chloro-4-methoxyphenyl)-2-(1,1-dioxo-2H-1lambda6,2,4-benzothiadiazin-3-yl)acetamide
950452-31-0
2-(1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-N-(4-ethoxyphenyl)acetamide
53971-23-6
N-(4-chlorophenyl)-2-(1,1-dioxido-2H-benzo[e][1,2,4]thiadiazin-3-yl)acetamide
951460-64-3
N-(5-chloro-2-methylphenyl)-2-(1,1-dioxido-2H-benzo[e][1,2,4]thiadiazin-3-yl)acetamide
951553-90-5
N-(2-chloro-4-methylphenyl)-2-(1,1-dioxo-2H-1lambda6,2,4-benzothiadiazin-3-yl)acetamide
951540-88-8
N-(3-chloro-4-methylphenyl)-2-(1,1-dioxido-2H-benzo[e][1,2,4]thiadiazin-3-yl)acetamide
950452-34-3
N-(3-chloro-2-methylphenyl)-2-(1,1-dioxo-2H-1lambda6,2,4-benzothiadiazin-3-yl)acetamide
951460-68-7
N-(3-bromophenyl)-2-(1,1-dioxo-2H-1lambda6,2,4-benzothiadiazin-3-yl)acetamide
951553-94-9
4-(2-(1,1-dioxido-2H-benzo[e][1,2,4]thiadiazin-3-yl)acetamido)benzamide
950452-37-6
2-(1,1-dioxo-2H-1lambda6,2,4-benzothiadiazin-3-yl)-N-(4-phenoxyphenyl)acetamide
951460-72-3